Bloomberg Anywhere Remote Login Bloomberg Terminal Request a Demo

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $302.26 USD
Change Today +0.63 / 0.21%
Volume 1.7M
As of 8:10 PM 09/4/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Douglas Edward Williams Ph.D.

AgeTotal Calculated CompensationThis person is connected to 59 board members in 5 different organizations across 15 different industries.

See Board Relationships
57$104,159
As of Fiscal Year 2013

Background*

Dr. Douglas Edward Williams, also known as Doug, Ph.D. served as an Executive Vice President of Research & Development at Biogen Inc. since January 5, 2011 until July 10, 2015. Dr. Williams served as the Chief Executive Officer of Zymogenetics Inc. from January 2, 2009 to November 2010. Dr. Williams served as the President of Zymogenetics Inc. from July 2, 2007 to January 2009. Dr. Williams joined ZymoGenetics Inc. on September 7, 2004 as Chief Scientific Officer and ...

Read Full Background

Corporate Headquarters*

225 Binney Street
Cambridge, Massachusetts 02142

United States

Phone: 617-679-2000
Fax: --

Board Members Memberships*

2006-Present
Director
2012-Present
Director
2014-Present
Director and Member of Governance & Nominating Committee

Education*

PhD
State University of New York at Buffalo Roswell Park Memorial Institute Division
BS
University of Massachusetts Lowell

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

Total Annual Cash Compensation$32,000
Total Calculated Compensation$104,159
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
BIIB:US $302.26 USD +0.63

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Ali Mortazavi Chief Executive (leave of absence) and Director
Silence Therapeutics plc
200.0K GBP
Peter French B.Sc, M.Sc, Ph.D., MBAChief Executive Officer, Managing Director and Director
Benitec Biopharma Limited
A$400.0K
Mark W. Schwartz Ph.D.Chief Executive Officer, President, Director and Member of Ad Hoc (Strategy, Pricing, Etc) Committee
Galena Biopharma, Inc.
$707.1K
Mark Joseph Murray Ph.D.Chief Executive Officer, President and Director
Arbutus Biopharma Corporation
$580.0K
Douglas M. Fambrough III, Ph.D.Co-Founder, Chief Executive Officer, President and Director
Dicerna Pharmaceuticals, Inc.
$430.0K
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact BIOGEN INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.